Search Orphan Drug Designations and Approvals
-
Generic Name: | Andecaliximab |
---|---|
Date Designated: | 03/19/2024 |
Orphan Designation: | Treatment of fibrodysplasia ossificans progressiva |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ashibio Inc 2000 Sierra Point Parkway Suite 701 Brisbane,, California 94005 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-